Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer

Abstract

BackgroundGenome-wide miRNA expression profile has identified microRNA (miR)-96 as one of upregulated miRNAs in clinical bladder cancer (BC) tissues compared to normal bladder tissues. The aim of this study was to confirm the expression pattern of miR-96 in BC tissues and to investigate its involvement in carcinogenesis.MethodsQuantitative real-time PCR was performed to detect the expression levels of miR-96 in 60 BC and 40 normal control tissues. Bioinformatics prediction combined with luciferase reporter assay were used to verify whether the cyclin-dependent kinase inhibitor CDKN1A was a potential target gene of miR-96. Cell counting kit-8 and apoptosis assays were further performed to evaluate the effects of miR-96-CDKN1A axis on cell proliferation and apoptosis of BC cell lines.ResultsWe validated that miR-96 was significantly increased in both human BC tissues and cell lines. According to the data of miRTarBase, CDKN1A might be a candidate target gene of miR-96. In addition, luciferase reporter and Western blot assays respectively demonstrated that miR-96 could bind to the putative seed region in CDKN1A mRNA 3′UTR, and significantly reduce the expression level of CDKN1A protein. Moreover, we found that the inhibition of miR-96 expression remarkably decreased cell proliferation and promoted cell apoptosis of BC cell lines, which was consistent with the findings observed following the introduction of CDKN1A cDNA without 3′UTR restored miR-96.ConclusionsOur data reveal that miR-96 may function as an onco-miRNA in BC. Upregulation of miR-96 may contribute to aggressive malignancy partly through suppressing CDKN1A protein expression in BC cells.

The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model

“…miR-3934 predicted targets include components of the oncogenic Wnt signaling pathway such as WNT7, WNT9A, MAPK10, APC and ROCK2 [17]. The up-regulated miRNAs in all 21T cell lines, suggesting an early event in tumorigenesis include the oncomiRs miR-29a/b/c [18, 19], miR-141 [20, 21], miR106b [22] and miR-96 [23, 24]. In this study, we focus our attention at the miRNA profile during the progression from an in situ tumor to a metastatic phenotype.…”

HDAC2‐dependent miRNA signature in acute myeloid leukemia

“…Low expression levels of miR-96-5p were found in a specific cohort of AML patients, suggesting that this epigenetic marker could be considered a prognostic factor for AML at diagnosis [27]. miR-96-5p upregulation acts as an antiapoptotic factor in bladder cells, as it negatively regulates specific targets such as CDKN1A, which is involved in cell cycle regulation and DNA damage pathway in bladder cancer [28]. Our data show that TRIB3 is targeted by miR-96-5p.…”

CTP synthase regulation by miR-975 controls cell proliferation and differentiation inDrosophila melanogaster

“…An inverse relationship with carcinogenesis is thusly expected in most cases. Several miRNAs are nonetheless known to encourage the progression of certain cancer types such as lung and hepatocellular carcinoma, rather than repressing them (Su et al, 2014;Wu et al, 2015). The trio-clustered hsamiRNAs 371, 372, and 373 have proven themselves to be potent oncogenes.…”